Pacific Biosciences of California (PACB) News Today → Time is Running Out - June 25th Deadline Approaching! (From Paradigm Press) (Ad) Free PACB Stock Alerts $2.01 -0.04 (-1.95%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 5 at 2:41 PM | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Trading Up 8.1%Pacific Biosciences of California (NASDAQ:PACB) Shares Up 8.1%June 5 at 6:58 AM | americanbankingnews.comPacific Biosciences of California (NASDAQ:PACB) Shares Gap Up to $1.79June 5 at 4:44 AM | marketbeat.com1,374,715 Shares in Pacific Biosciences of California, Inc. (NASDAQ:PACB) Acquired by Norges BankNorges Bank acquired a new position in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 1,374,715 shares of the biotechnology company's stock, valued at approximately $13,48June 3, 2024 | americanbankingnews.comPacific Biosciences of California (NASDAQ:PACB) Now Covered by Analysts at Jefferies Financial GroupJune 3, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Coverage Initiated by Analysts at Jefferies Financial GroupJefferies Financial Group began coverage on shares of Pacific Biosciences of California in a research report on Monday. They set a "buy" rating and a $4.00 target price for the company.June 3, 2024 | seekingalpha.comPacific Biosciences: Navigating Rough Waters In Gene Sequencing SeasMay 30, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Shares Gap Down to $1.82Pacific Biosciences of California (NASDAQ:PACB) Shares Gap Down to $1.82May 30, 2024 | marketbeat.comDecheng Capital LLC Acquires New Stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Decheng Capital LLC acquired a new stake in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 2,940,361 shares of the biotechnology company's stock, valued at apMay 27, 2024 | msn.comPacific Coast Highway blocked along stretch in Malibu due to small landslideMay 24, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Trading Down 2.3%Pacific Biosciences of California (NASDAQ:PACB) Stock Price Down 2.3%May 23, 2024 | insidertrades.comInsider Selling: Pacific Biosciences of California, Inc. (NASDAQ:PACB) Insider Sells 5,275 Shares of StockMay 22, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Stock Price Up 7.4%Pacific Biosciences of California (NASDAQ:PACB) Trading 7.4% HigherMay 18, 2024 | marketbeat.comJackson Square Partners LLC Acquires 2,770,901 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB)Jackson Square Partners LLC increased its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 40.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 9,704,766 shares of the biotMay 15, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Stock Price Down 5.6% on Analyst DowngradePacific Biosciences of California (NASDAQ:PACB) Trading Down 5.6% Following Analyst DowngradeMay 15, 2024 | marketbeat.comMorgan Stanley Trims Pacific Biosciences of California (NASDAQ:PACB) Target Price to $4.00Morgan Stanley decreased their price objective on Pacific Biosciences of California from $10.00 to $4.00 and set an "equal weight" rating for the company in a report on Wednesday.May 15, 2024 | prnewswire.comAmbry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare DiseasesMay 15, 2024 | marketbeat.comFY2024 EPS Estimates for Pacific Biosciences of California, Inc. Raised by Cantor Fitzgerald (NASDAQ:PACB)Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) - Investment analysts at Cantor Fitzgerald boosted their FY2024 earnings per share (EPS) estimates for shares of Pacific Biosciences of California in a research report issued on Monday, May 13th. Cantor Fitzgerald analyst R. OsboMay 15, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Lifted to "Sell" at StockNews.comStockNews.com upgraded Pacific Biosciences of California to a "sell" rating in a report on Tuesday.May 14, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Liquidia Technologies (LQDA) and Pacific Biosciences (PACB)May 14, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Shares Gap Up to $1.93Pacific Biosciences of California (NASDAQ:PACB) Shares Gap Up to $1.93May 13, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Shares Up 11.9%Pacific Biosciences of California (NASDAQ:PACB) Trading Up 11.9%May 13, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Given New $2.00 Price Target at Piper SandlerPiper Sandler dropped their target price on Pacific Biosciences of California from $6.50 to $2.00 and set a "neutral" rating for the company in a research report on Monday.May 13, 2024 | marketbeat.comVictory Capital Management Inc. Acquires 442,250 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB)Victory Capital Management Inc. lifted its holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 67.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,094,724 shares of the biotechnMay 11, 2024 | finance.yahoo.comPacific Biosciences of California First Quarter 2024 Earnings: Misses ExpectationsMay 10, 2024 | markets.businessinsider.comOptimistic Outlook: Buy Rating on Pacific Biosciences Amidst Turnaround Efforts and Long-term Growth PotentialMay 10, 2024 | insidermonkey.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2024 Earnings Call TranscriptMay 9, 2024 | seekingalpha.comPacific Biosciences of California, Inc. 2024 Q1 - Results - Earnings Call PresentationMay 9, 2024 | markets.businessinsider.comPacific Biosciences Of California, Inc. Q1 Loss Decreases, Beats EstimatesMay 9, 2024 | prnewswire.comPacBio Announces First Quarter 2024 Financial ResultsMay 8, 2024 | markets.businessinsider.comPacific Biosciences of California is about to announce its earnings — here's what to expectMay 7, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Trading Down 5.3%Pacific Biosciences of California (NASDAQ:PACB) Shares Down 5.3%May 6, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Trading 10.1% Higher Pacific Biosciences of California (NASDAQ:PACB) Stock Price Up 10.1%May 4, 2024 | marketbeat.comVestmark Advisory Solutions Inc. Invests $4.85 Million in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Vestmark Advisory Solutions Inc. bought a new stake in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 494,790 shares of the biotechnology company's stock, valuMay 2, 2024 | tmcnet.comMedGenome announces de novo Genome Assembly and Annotation Grant winners for 2024April 30, 2024 | bizjournals.comLatest biotech cuts hit pioneering DNA sequencing company, Verily's eye-focused joint ventureApril 29, 2024 | marketbeat.comPacific Biosciences of California (PACB) Scheduled to Post Quarterly Earnings on TuesdayPacific Biosciences of California (NASDAQ:PACB) will be releasing earnings on Tuesday, April 30, Yahoo Finance reports.April 23, 2024 | msn.comJP Morgan Downgrades Pacific Biosciences of California (PACB)April 23, 2024 | marketbeat.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) have been assigned an average rating of "Moderate Buy" from the fifteen ratings firms that are presently covering the company, MarketBeat.com reports. Seven investment analysts have rated the stock with a hold recommeApril 22, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Lowered to "Neutral" at JPMorgan Chase & Co.JPMorgan Chase & Co. cut shares of Pacific Biosciences of California from an "overweight" rating to a "neutral" rating in a research note on Monday.April 18, 2024 | msn.comPacBio cut to Neutral at Goldman Sachs after guidance cutApril 18, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Pacific Biosciences (PACB) and Eli Lilly & Co (LLY)April 18, 2024 | msn.comPacific Biosciences of California (PACB) Price Target Decreased by 18.15% to 9.01April 17, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Price Target Cut to $2.50 by Analysts at TD CowenTD Cowen cut their price target on shares of Pacific Biosciences of California from $12.00 to $2.50 and set a "buy" rating for the company in a research note on Wednesday.April 17, 2024 | baystreet.caMid-Week Wednesday's Most Active BuysApril 16, 2024 | finanznachrichten.dePacific Biosciences of California, Inc.: PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue GuidanceApril 16, 2024 | investorplace.comThe Cathie Wood Stock Shuffle: 4 Names She's Loving, 3 She's LeavingApril 16, 2024 | msn.comPacBio falls after issuing guidance below expectationsApril 16, 2024 | markets.businessinsider.comPacBio Q1 Prel. Revenue Nearly Flat, Annual Revenue Outlook Below View; Stock DownApril 16, 2024 | finance.yahoo.comPacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue GuidanceApril 13, 2024 | marketbeat.comMirae Asset Global Investments Co. Ltd. Has $9.09 Million Stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Mirae Asset Global Investments Co. Ltd. decreased its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 35.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 926,9 Get Pacific Biosciences of California News Delivered to You Automatically Sign up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Email Address After Conviction, More Bad News for Trump (Ad)As a former advisor to the CIA, the Pentagon and the White House… I feel it’s my duty to warn you about this coming election meltdown. Click here to see the details because this coming election meltdown could trigger… PACB Media Mentions By Week PACB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PACB News Sentiment▼0.710.72▲Average Medical News Sentiment PACB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PACB Articles This Week▼74▲PACB Articles Average Week Get Pacific Biosciences of California News Delivered to You Automatically Sign up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: HBIO News Today LIFE News Today TMO News Today A News Today MTD News Today WAT News Today ILMN News Today TECH News Today CRL News Today BRKR News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PACB) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersWe’ve Made 1,000% … THREE Different Times in the Last Year (Here’s How)Bitcoin can and probably will hit the $1 MILLION level this decade. That’s more than 1,000% upside from the...Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | Sponsored